The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
Regular Contributions
Chronological Changes of CD4+ and CD8+ T Cell Subsets in the Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis
Yoshifumi SonobeShijie JinJinyan WangJun KawanokuchiHideyuki TakeuchiTetsuya MizunoAkio Suzumura
Author information
Keywords: EAE/MS, MHC, CD4, CD8, IL-17

Volume 213 (2007) Issue 4 Pages 329-339

Download PDF (439K) Contact us

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). The etiology of MS remains unclear, but T cells specific for myelin components, such as myelin oligodendrocyte glycoprotein (MOG), are thought to play a critical role in the onset of MS. Experimental autoimmune encephalomyelitis (EAE) has been used as an animal model of MS, and T helper type 1 (Th1) cells play an essential role for the pathogenesis of EAE through the production of Th1 cytokines, interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). We examined CD4+ and CD8+ T cell responses in the spleen and CNS of EAE mice, generated by immunization with a peptide (35-55 amino acid residues) of MOG. The number of both CD4+ and CD8+ T cells and their MOG-reactivity in the CNS were associated with increasing disease severity but not those in the spleen, suggesting that the MOG-specific CD4+ and CD8+ T cells in the CNS are involved in the development of EAE. Polymerase chain reaction analysis suggested that both CD4+ and CD8+ T cells produced IFN-γ and TNF-α, while CD4+ T cells also produced interleukin-17 (IL-17), an important factor in the development of EAE. Thus, CD4+ T cells may contribute to the induction of EAE by producing IL-17. Furthermore, CD8+ T cells express higher levels of a suppressive cytokine, IL-10. Taking together, our data suggest that CD4+ T cells are involved in the early phase of EAE, whereas CD8+ T cells have a regulatory role in the later stage of EAE.

Information related to the author
© 2007 Tohoku University Medical Press
Previous article Next article

Recently visited articles
  • About this Journal
    The Tohoku Journal of Experimental Medicine (TJEM) was founded in 1920 by professors of Tohoku Imperial University, Medical School. The TJEM has been published continuously, except for the year of 1946 just after the World War II. The TJEM is open to original articles in all branches of medical sciences. The TJEM also covers the fields of disaster-prevention science, including earthquake archeology.

  • Submitted manuscripts will be screened for plagiarism with Similarity Check (
Journal news & Announcements
  • Subscriptions
    Inland subscriptions should be sent to Tohoku University Medical Press, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, JAPAN.

    Subscriptions from abroad should be addressed to MARUZEN CO., LTD., EXPORT DEPARTMENT, Postal address: P.O.Box 75, Shinagawa, Tokyo 140-8799, JAPAN.